THOUSAND OAKS, Calif., Dec. 19, 2024 /PRNewswire/ — Capsida Biotherapeutics (“Capsida”), leader in next-generation IV-administered central nervous system (CNS) gene therapies, today announced it will present at the 43rd Annual J.P. Morgan Healthcare Conference. Chief Executive Officer…